NINA LEBLANC: Open Payments
NPI 1447831680 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$152 in 6 payments from 4 companies in 2025. Trend: 2023 $186 · 2024 $63 · 2025 $152
Food & beverage: $152
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $82 |
| ABBVIE INC. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Eisai Inc. | 1 | $20 |
Products named: KEYTRUDA, ELAHERE, LYNPARZA, JEMPERLI, Lenvima.
Industry payments across LA — which companies pay providers there.
